The market performance of Capricor Therapeutics Inc’s stock has been harmonious in recent times. Over the last year, the company’s stock reached its highest point at $18.14 on 10/04/24, while the lowest value for the same duration was $2.68 on 11/10/23.
52-week price history of CAPR Stock
A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Capricor Therapeutics Inc’s current trading price is 9.81% away from its 52-week high, while its distance from the 52-week low is 643.28%. The stock’s price range during this period has spanned from $2.68 to $18.14. In the Healthcare sector, the Capricor Therapeutics Inc’s shares surpassed a trading volume of approximately 4.59 million for the day, which was noticeably higher compared to the average daily volume of 9.2.16 million over the past three months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Market Capitalization and Financial Performance: An In-Depth Look
Capricor Therapeutics Inc (CAPR) has experienced a quarterly rise of 317.61% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 648.20M and boasts a workforce of 102 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 5.59, with a change in price of +15.58. Similarly, Capricor Therapeutics Inc recorded 1,588,937 in trading volume during the last 100 days, posting a change of +286.40%.
Examining CAPR’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for CAPR stands at 0.45. Similarly, the long-term debt-to-equity ratio is also 0.38.
CAPR Stock Stochastic Average
Today’s raw stochastic average for Capricor Therapeutics Inc over the last 50 days is 99.12%.This indicates a increase from the raw stochastic average of the past 20 days, which was 99.09%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 93.36% and 89.08%, respectively.
CAPR Stock Price Performance Analysis
The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. The metric has seen a significant gain of 307.36% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 196.43%. Over the past 30 days, the price of CAPR has fallen by 369.81%. And in the last five days, it has surged by 100.20%.
